Your Position: Home - Chemicals - MK-1084

MK-1084

Author:jknbiochem 2025-09-26 17:40:24 23 0 0

Note: All products of the company are for scientific research only, and do not provide products and services for any individual

 

CAS

2641216-67-1

Cat No

JKN03248

Name

MK-1084

Synonyms

MK-1084

Smiles

CC1CN(C(CN1C(=O)C=C)C)C2=NC(=O)N3C4=C(C=CN=C4C(C)C)OCCOC5=C(C=CC(=C5C6=C(C=C2C3=N6)Cl)F)F

Chemical Name

19-chloro-22-(2,5-dimethyl-4-prop-2-enoylpiperazin-1-yl)-13,16-difluoro-3-propan-2-yl-8,11-dioxa-1,4,23,26-tetrazapentacyclo[16.6.2.02,7.012,17.021,25]hexacosa-2(7),3,5,12,14,16,18,20,22,25-decaen-24-one

Formula

C32H31ClF2N6O4

MWt

637.1

Purity

98%

Storage

Store at 4--8℃

Description

MK-1084 is a selective KRAS G12C inhibitor currently in Phase I clinical trials

 

At Jingkangen Biomedical, we focus on the discovery, synthesis, and supply of advanced signaling pathway drugs that support pharmaceutical R&D and biomedical research. Our expertise in JKN Signaling pathway solutions enables scientists to explore key molecular mechanisms and accelerate the development of innovative therapeutics.

 

Explore Our Signaling Pathway Portfolio

Signaling pathways play a crucial role in regulating cellular activities such as growth, apoptosis, immune response, and disease progression. To meet the diverse needs of global researchers, Jingkang en Biomedical provides a wide range of signaling pathway modulators and related compounds, designed for both academic research and drug development.

 

Pathway-specific small molecules – high-purity reagents to target oncology, immunology, neurology, and metabolic diseases.

 

Custom synthesis services – tailored solutions for new drug targets and pathway exploration.

 

Reference compounds & intermediates – ensuring reproducibility and reliability in research.

 

Discover more products: Our Products


Comments   Please sign in or sign up to post.

0

0 of 500 characters used

Copyright:@2020-2021